<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9822">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05689515</url>
  </required_header>
  <id_info>
    <org_study_id>HSC20220752H</org_study_id>
    <secondary_id>5R34MH122332-03</secondary_id>
    <nct_id>NCT05689515</nct_id>
  </id_info>
  <brief_title>Feasibility of Positive Links for Youth Care Engagement Intervention</brief_title>
  <official_title>PL4Y: A Pilot Randomized Control Trial to Study the Feasibility of Positive Links for Youth Care Engagement Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center at San Antonio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A small pilot study to assess feasibility and acceptability of the PL4Y intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After completing enrollment and informed consent, participants will be randomly assigned to&#xD;
      PL4Y in a 2:1 fashion (intervention:control) with a target enrollment of 40 receiving the&#xD;
      intervention and 20 in the control arm for a total of 60 participants. There is no blinding&#xD;
      in this study protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2023</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized in a 2:1 ratio to intervention (PL4Y use) or standard of care</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Completion of Feasibility Survey</measure>
    <time_frame>12 months</time_frame>
    <description>Feasibility survey completion by participants regarding usability of the PL4Y intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Viral plasma load measurement</measure>
    <time_frame>12 months</time_frame>
    <description>Virologic suppression is the primary goal of HIV treatment. Virologic failure is defined as a measurement over 200 copies per mL by the Department of Health and Human Services, and is the primary determinant of successful HIV control.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>HIV Antibody Positivity</condition>
  <arm_group>
    <arm_group_label>Mobile Health App group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mobile health app to increase rates of engagement in care in youths living with HIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care for youths living with HIV</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobile health app</intervention_name>
    <description>A mobile app provided to participants to assess effectiveness in managing HIV</description>
    <arm_group_label>Mobile Health App group</arm_group_label>
    <other_name>PL4Y</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed HIV infection&#xD;
&#xD;
          -  Recent diagnosis of HIV (within the past 6 months) OR be virologically unsuppressed&#xD;
             (&gt;1000 copies/ml) OR disengaged from HIV care (&lt; 2 visits/last 12 months &gt; 90 days&#xD;
             apart)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cannot consent&#xD;
&#xD;
          -  Unwilling to come to visits&#xD;
&#xD;
          -  Unwilling to be in San Antonio for a year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Taylor, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Health Science Center San Antonio</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Taylor, MD, MS</last_name>
    <phone>(210) 567-4661</phone>
    <email>taylorb4@uthscsa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruby Viera Corral</last_name>
    <phone>(210) 567-4709</phone>
    <email>vieracorral@uthscsa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Health Center Downtown</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Taylor, MD</last_name>
      <phone>210-450-8114</phone>
      <email>taylorb4@uthscsa.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>January 9, 2023</study_first_submitted>
  <study_first_submitted_qc>January 9, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>February 8, 2023</last_update_submitted>
  <last_update_submitted_qc>February 8, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Positive Links</keyword>
  <keyword>Youth</keyword>
  <keyword>Emerging Adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Seropositivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The research team will compose a manuscript including data on preliminary efficacy of the PL4Y program in YLWH with regards to virologic suppression, retention in care, stigma, self-efficacy, and social support. The study team will also have a detailed guide to operating procedures, including successful recruitment and retention techniques and study processes such as teching tarticipants how to use PL4Y and monitoring the community message board. All data regarding participants will be shared as de-identified data.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>At study completion and when all data have been analyzed to publish in a peer reviewed journal.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

